A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-compound, Multi-target, Multi-pathway Mode of Action

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 May 13

PMID 24817581

Citations 53

Authors

Xiang Li

Leihong Wu

Wei Liu

Yecheng Jin

Qian Chen

Linli Wang

Xiaohui Fan

Zheng Li

Yiyu Cheng

Affiliations

Soon will be listed here.

Abstract

Chinese medicine is a complex system guided by traditional Chinese medicine (TCM) theories, which has proven to be especially effective in treating chronic and complex diseases. However, the underlying modes of action (MOA) are not always systematically investigated. Herein, a systematic study was designed to elucidate the multi-compound, multi-target and multi-pathway MOA of a Chinese medicine, QiShenYiQi (QSYQ), on myocardial infarction. QSYQ is composed of Astragalus membranaceus (Huangqi), Salvia miltiorrhiza (Danshen), Panax notoginseng (Sanqi), and Dalbergia odorifera (Jiangxiang). Male Sprague Dawley rat model of myocardial infarction were administered QSYQ intragastrically for 7 days while the control group was not treated. The differentially expressed genes (DEGs) were identified from myocardial infarction rat model treated with QSYQ, followed by constructing a cardiovascular disease (CVD)-related multilevel compound-target-pathway network connecting main compounds to those DEGs supported by literature evidences and the pathways that are functionally enriched in ArrayTrack. 55 potential targets of QSYQ were identified, of which 14 were confirmed in CVD-related literatures with experimental supporting evidences. Furthermore, three sesquiterpene components of QSYQ, Trans-nerolidol, (3S,6S,7R)-3,7,11-trimethyl-3,6-epoxy-1,10-dodecadien-7-ol and (3S,6R,7R)-3,7,11-trimethyl-3,6-epoxy-1,10-dodecadien-7-ol from Dalbergia odorifera T. Chen, were validated experimentally in this study. Their anti-inflammatory effects and potential targets including extracellular signal-regulated kinase-1/2, peroxisome proliferator-activated receptor-gamma and heme oxygenase-1 were identified. Finally, through a three-level compound-target-pathway network with experimental analysis, our study depicts a complex MOA of QSYQ on myocardial infarction.

Citing Articles

Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation.

Fan X, Liu S, Yu J, Hua J, Feng Y, Wang Z Drug Des Devel Ther. 2025; 19:737-757.

PMID: 39911447 PMC: 11796443. DOI: 10.2147/DDDT.S487496.

UHPLC-Q-Orbitrap HRMS and network analysis to explore the mechanisms of QiShenYiQi dripping pill for treating myocardial infarction.

Liu Z, Fu H, Gan Y, Ye Y, Huang B, Jiang M Front Pharmacol. 2024; 15:1443560.

PMID: 39555088 PMC: 11563805. DOI: 10.3389/fphar.2024.1443560.

Protective effects of Shexiang-Tongxin dropping pill against acute myocardial infarction in rats through inhibition of apoptosis and ERK/MAPK signaling pathways.

Yan J, Liu H, Shang J, Fang Q, Ye J, Lu X Heliyon. 2024; 10(21):e39939.

PMID: 39553562 PMC: 11565526. DOI: 10.1016/j.heliyon.2024.e39939.

Development of a high-speed and ultrasensitive UV/Vis-CM for detecting total triterpenes in traditional Chinese medicine and its application.

Guo Y, Han Z, Zhang J, Lu Y, Li C, Liu G Heliyon. 2024; 10(11):e32239.

PMID: 38882362 PMC: 11180301. DOI: 10.1016/j.heliyon.2024.e32239.

Development of Novel Herbal Compound Formulations Targeting Neuroinflammation: Network Pharmacology, Molecular Docking, and Experimental Verification.

Liu Y, Chang D, Zhou X Evid Based Complement Alternat Med. 2023; 2023:2558415.

PMID: 37266321 PMC: 10232107. DOI: 10.1155/2023/2558415.

References

Wu G, Fang Y, Yang S, Lupton J, Turner N . Glutathione metabolism and its implications for health. J Nutr. 2004; 134(3):489-92. DOI: 10.1093/jn/134.3.489. View

Aramoto H, Breslin J, Pappas P, Hobson 2nd R, Duran W . Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol. 2004; 287(4):H1590-8. DOI: 10.1152/ajpheart.00767.2003. View

Burns K, Vanden Heuvel J . Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta. 2007; 1771(8):952-60. PMC: 2712836. DOI: 10.1016/j.bbalip.2007.04.018. View

Campbell I . The Clinical Significance of PPAR Gamma Agonism. Curr Mol Med. 2005; 5(3):349-63. DOI: 10.2174/1566524053766068. View

Robinson E, Khankin E, Karumanchi S, Humphreys B . Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker. Semin Nephrol. 2010; 30(6):591-601. PMC: 3058726. DOI: 10.1016/j.semnephrol.2010.09.007. View

Tao Y, Wang Y . Bioactive sesquiterpenes isolated from the essential oil of Dalbergia odorifera T. Chen. Fitoterapia. 2009; 81(5):393-6. DOI: 10.1016/j.fitote.2009.11.012. View

Terzic A, Waldman S . Chronic diseases: the emerging pandemic. Clin Transl Sci. 2011; 4(3):225-6. PMC: 5439863. DOI: 10.1111/j.1752-8062.2011.00295.x. View

Adams M, Reginato M, Shao D, Lazar M, Chatterjee V . Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem. 1997; 272(8):5128-32. DOI: 10.1074/jbc.272.8.5128. View

di Bernardo D, Thompson M, Gardner T, Chobot S, Eastwood E, Wojtovich A . Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat Biotechnol. 2005; 23(3):377-83. DOI: 10.1038/nbt1075. View

10.

Waldman S, Terzic A . Cardiovascular health: the global challenge. Clin Pharmacol Ther. 2011; 90(4):483-5. DOI: 10.1038/clpt.2011.213. View

11.

Barber G . Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol. 2011; 23(1):10-20. PMC: 3881186. DOI: 10.1016/j.coi.2010.12.015. View

12.

Kaminska B . MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005; 1754(1-2):253-62. DOI: 10.1016/j.bbapap.2005.08.017. View

13.

Kitano H . Systems biology: a brief overview. Science. 2002; 295(5560):1662-4. DOI: 10.1126/science.1069492. View

14.

Zheng X, Zhao X, Wang S, Luo K, Wei Y, Zheng J . Co-administration of Dalbergia odorifera increased bioavailability of Salvia miltiorrhizae in rabbits. Am J Chin Med. 2007; 35(5):831-40. DOI: 10.1142/S0192415X07005302. View

15.

Kim B, Choi J, Hong H, Lee S, Hong S, Park E . Heme oxygenase-1 mediates the anti-inflammatory effect of mushroom Phellinus linteus in LPS-stimulated RAW264.7 macrophages. J Ethnopharmacol. 2006; 106(3):364-71. DOI: 10.1016/j.jep.2006.01.009. View

16.

Cheung F . TCM: Made in China. Nature. 2011; 480(7378):S82-3. DOI: 10.1038/480S82a. View

17.

Finck B . The PPAR regulatory system in cardiac physiology and disease. Cardiovasc Res. 2006; 73(2):269-77. DOI: 10.1016/j.cardiores.2006.08.023. View

18.

Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock I . Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol. 2007; 27(6):1276-82. DOI: 10.1161/ATVBAHA.107.142638. View

19.

Petit V, Thiery J . Focal adhesions: structure and dynamics. Biol Cell. 2001; 92(7):477-94. DOI: 10.1016/s0248-4900(00)01101-1. View

20.

Diez D, Wheelock A, Goto S, Haeggstrom J, Paulsson-Berne G, Hansson G . The use of network analyses for elucidating mechanisms in cardiovascular disease. Mol Biosyst. 2010; 6(2):289-304. DOI: 10.1039/b912078e. View